by NanoVation | Sep 18, 2024 | 2024, News
News NanoVation Therapeutics announces multi-target partnership with Novo Nordisk to develop genetic medicines targeting cardiometabolic and rare diseases NanoVation will receive research funding and is eligible to receive up to approximately US$600 million in...
by NanoVation | Aug 14, 2024 | 2024, Events
Event NanoVation CSO featured on BIO Podcast NanoVation Co-founder and CSO Dr. Jayesh Kulkarni was interviewed for the BIO Podcast at the BIO International Convention in San Diego, USA, in June 2024. He also spoke at the event on the topic “Exploring the Future...
by NanoVation | Aug 13, 2024 | 2024, 2024, News, Publications
Publication NTx chemistry team publishes in J. of Organic Chemistry Claisen Self-Condensation of Lactones in the Synthesis of Ionizable Lipids Nabi et al. 13 August 2024 Co-authored by NanoVation’s Ardalan Nabi, N. D. Prasad Atmuri, Deaglan Arnold, Fariba Saadati, Huy...
by NanoVation | Aug 3, 2024 | 2024, Events
Event NanoVation CEO interviewed @ Applied Biophysics Forum NanoVation Co-founder and CEO Dominik Witzigmann was interviewed on-site at the Applied Biophysics Forum in Drug Delivery in Copenhagen, Denmark, in May 2024. Dr. Witzimann was also a speaker at the event,...
by NanoVation | May 24, 2024 | 2024, Events
Event NTx CSO in BC Delegation Spotlight @ BIO San Diego NanoVation Therapeutics was honored to take part in the “BC Delegation Spotlight: BIO San Diego” virtual event, hosted by Life Sciences BC (LSBC) on May 23rd. Our CSO Jayesh Kulkarni highlighted our...
by NanoVation | Apr 23, 2024 | 2024, Events
Event Dame Molly Stevens @ ScSB summit We’re proud to share that Dr. Molly Stevens, an esteemed Oxford professor and a key scientific advisor to NanoVation, will be presenting at the Scandinavian Society for Biomaterials (ScSB) Annual Meeting – or ScSB...
